Pediatrix Medical Group Inc (NYSE:MD) shares, rose in value, with the stock price up by 1.57% to the previous day’s close as strong demand from buyers drove the stock to $9.04.
Actively observing the price movement in the last trading, the stock closed the session at $8.90. Referring to stock’s 52-week performance, its high was $15.06, and the low was $7.70. On the whole, MD has fluctuated by -9.51% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.04B, with a low estimate of 492.1M and a high estimate of 504.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 499.08M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MD’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MD currently trading nearly -2.68% and -1.62% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.07, while the 7-day volatility ratio is showing 4.17% which for the 30-day chart, stands at 3.16%. Furthermore, Pediatrix Medical Group Inc (MD)’s beta value is 1.59, and its average true range (ATR) is 0.32.
A comparison of Pediatrix Medical Group Inc (MD) with its peers suggests the former has fared considerably weaker in the market. MD showed an intraday change of 1.57% in last session, and over the past year, it shrunk by -35.66%%.
Data on historical trading for Pediatrix Medical Group Inc (NYSE:MD) indicates that the trading volumes over the past 3 months, they’ve averaged 675.64K. According to company’s latest data on outstanding shares, there are 84.12 million shares outstanding.
Nearly 1.18% of Pediatrix Medical Group Inc’s shares belong to company insiders and institutional investors own 98.18% of the company’s shares. The stock has fallen by -2.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MD stock heading into the next quarter.
